Li and colleagues uncovered a novel lncRNA-encoded polypeptide, termed micropeptide MIAC, which weakens cancer cell growth and metastasis and accelerates apoptosis in renal cell carcinoma by inactivating the pathway of EREG/EGFR (Li et al. 2022). This evidence concerns the gene EGFR and hereditary clear cell renal cell carcinoma.